Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A synthetic small molecule with the chemical formula C13H9Cl2NO5 and a molecular weight of approximately 330.12 g/mol. It features a benzoic acid backbone substituted with a dichlorinated phenyl ring bearing a trioxidanyl (hydroxyperoxy) group. The compound is classified as experimental and has not been approved for any therapeutic use or clinical indication to date. No detailed mechanism of action or pharmacological activity has been established in the literature; it is primarily referenced in chemical and drug databases as an experimental entity[1][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 2-[(3,5-dichloro-4-trioxidanylphenyl)amino]benzoic acid.